HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN Pharmacologic Class Indexing
- Class set ID
- ab08bf96-d329-449d-a67a-38937d8266ec
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use VAXELIS safely and effectively. See full prescribing information for VAXELIS. VAXELIS ® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) injectable suspension, for intramuscular use Initial U.S. Approval: 2018 | MSP Vaccine Company | Sanofi Vaccines Canada Ltd. | Sanofi Winthrop Industrie | Merck Sharp & Dohme Corp. | 20260428 | 14 |
| RECOMBIVAX HB® Hepatitis B Vaccine (Recombinant) Suspension for intramuscular injection Initial U.S. Approval: 1986 These highlights do not include all the information needed to use RECOMBIVAX HB safely and effectively. See full prescribing information for RECOMBIVAX HB. | Bamboo US BidCo LLC | 20260305 | 1 |
| These highlights do not include all the information needed to use HEPLISAV-B ® safely and effectively. See full prescribing information for HEPLISAV-B. HEPLISAV-B [Hepatitis B Vaccine (Recombinant), Adjuvanted] injection, for intramuscular use Initial U.S. Approval: 2017 | Dynavax Technologies Corporation | Rhein Biotech GmbH | 20260219 | 10 |
| These highlights do not include all the information needed to use HEPLISAV-B ® safely and effectively. See full prescribing information for HEPLISAV-B. HEPLISAV-B [Hepatitis B Vaccine (Recombinant), Adjuvanted] Solution for Intramuscular Injection Initial U.S. Approval: 2017 | Bamboo US BidCo LLC | Dynavax Technologies Corporation | 20260202 | 5 |
| These highlights do not include all the information needed to use VAXELIS safely and effectively. See full prescribing information for VAXELIS. VAXELIS ® (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) Suspension for Intramuscular Injection Initial U.S. Approval: 2018 | A-S Medication Solutions | 20250513 | 1 |
| These highlights do not include all the information needed to use HEPLISAV-B ® safely and effectively. See full prescribing information for HEPLISAV-B. HEPLISAV-B [Hepatitis B Vaccine (Recombinant), Adjuvanted] injection, for intramuscular use Initial U.S. Approval: 2017 | A-S Medication Solutions | 20250416 | 10 |
| These highlights do not include all the information needed to use RECOMBIVAX HB safely and effectively. See full prescribing information for RECOMBIVAX HB. RECOMBIVAX HB® Hepatitis B Vaccine (Recombinant) Suspension for intramuscular injection Initial U.S. Approval: 1986 | Merck Sharp & Dohme LLC | 20241031 | 32 |
| These highlights do not include all the information needed to use RECOMBIVAX HB safely and effectively. See full prescribing information for RECOMBIVAX HB. RECOMBIVAX HB® Hepatitis B Vaccine (Recombinant) Suspension for intramuscular injection Initial U.S. Approval: 1986 | A-S Medication Solutions | 20210616 | 16 |
| These highlights do not include all the information needed to use RECOMBIVAX HB safely and effectively. See full prescribing information for RECOMBIVAX HB. RECOMBIVAX HB® Hepatitis B Vaccine (Recombinant) Suspension for intramuscular injection Initial U.S. Approval: 1986 | A-S Medication Solutions | 20210616 | 16 |
| These highlights do not include all the information needed to use RECOMBIVAX HB safely and effectively. See full prescribing information for RECOMBIVAX HB. RECOMBIVAX HB® Hepatitis B Vaccine (Recombinant) Suspension for intramuscular injection Initial U.S. Approval: 1986 | A-S Medication Solutions | 20210616 | 15 |
| HEP B SURFACE ANTIGEN 80MCG/ML EU | Merck Sharp & Dohme Corp. | 20150805 | 3 |